CLINICAL_TRIALS
trial_result
· 2014-07-08
Clinical Trial Update: BIBR 277 Capsule in Patients With Essential Hypertension [Phase 3]
Summary
Phase 3 trial update: Boehringer Ingelheim's BIBR 277 Capsule in essential hypertension has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Phase 3 | Status: COMPLETED